The Role of PORT in Patients With Completely Resected Stage III-N2 NSCLC: A Pro/Con - The Pro Side

Deeper Dive Toxicity of Lung SBRT and Concurrent Immunotherapy Combinations: What We Know and What We Still Need to Learn

The Dandelion Dilemma of Brain Metastases: Treating the Whole Lawn or the Weeds Separately

PET vs. CT in Lung Cancer Surveillance: The ‘Pro’ Side from the Nuclear Medicine Perspective

Patient Perspectives on CT and PET Scans: Imaging Technology Provides Different Benefits, Drawbacks for Each Individual Patient

FDG PET–CT Versus CT for Lung Cancer Surveillance: The "Con" Side

SBRT Versus Surgery in the COVID-19 Era: What Has Changed and What Hasn't?

Questions Remain Following Long-Term Results of the Phase II SABR-COMET Trial 

The Immune System: A New Organ at Risk in Lung Cancer Radiation Therapy?

Understanding the Promising Role of Stereotactic Ablative Radiotherapy in Treating Patients With Oligometastatic Disease

Cardiac Radiation Dose, Cardiac Events, and Survival in Locally Advanced NSCLC

Brain Metastases in NSCLC: Is Delaying Upfront Radiation a Viable Option?